Capsular Interposition Arthroplasty for End-Stage Hallux Rigidus: Short-Term Results

Research Article

Foot Ankle Stud. 2018; 2(1): 1010.

Capsular Interposition Arthroplasty for End-Stage Hallux Rigidus: Short-Term Results

Kanazawa K*, Yoshimura I, Hagio T, Minokawa S and Yamamoto T

Department of Orthopaedic Surgery, Fukuoka University School of Medicine, Japan

*Corresponding author: Kanazawa K, Department of Orthopaedic Surgery, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan

Received: May 02, 2018; Accepted: May 31, 2018; Published: June 11, 2018

Abstract

Background: Hallux rigidus is a common consequence of degenerative arthritis of the first Metatarsophalangeal (MTP) joint. Capsular Interposition Arthroplasty (CIA) is a motion-sparing procedure that has been shown to be effective as an alternative to fusion in end-stage hallux rigidus.

Objective: The study aimed to assess the results of CIA in patients with hallux rigidus.

Methods: Ten patients (10 feet) with Grade III hallux rigidus (per the Hattrup classification) underwent CIA of the first MTP joint in our institution. The mean age was 67.1 years and mean duration of follow-up was 16.8 months (range, 12-23). Preoperative and postoperative Ranges of Motion (ROMs) of the hallux MTP joint were measured and compared. Clinical evaluations involved the 5 subscales of the Self-Administered Foot Evaluation Questionnaire (SAFE-Q) and the Japan Society for Surgery of the Foot (JSSF) score.

Results: The mean ROM for extension improved from 6.5° to 31.0°, and mean ROM for flexion improved from 11.5° to 26.0°. The mean SAFE-Q scale scores significantly improved in all patients after surgery. The mean JSSF score significantly improved from a preoperative 49.9 points to a postoperative 82.5 points. The overall complication rate was 10% (1/10), and involved the breakage of a K-wire in 1 foot.

Conclusion: CIA is an acceptable choice for patients with grade III hallux rigidus who desire preservation of articular function.

Keywords: Hallux rigidus; Degenerative arthritis; First metatarsophalangeal joint; Operative technique; Motion-sparing procedures; Capsular interposition arthroplasty 

Abbreviations

Capsular Interposition Arthroplasty (CIA); Japan Society for Surgery of the Foot (JSSF); Metatarsophalangeal (MTP); Range/S of Motion (ROM/s); Self-Administered Foot Evaluation Questionnaire (SAFE-Q)

Introduction

Hallux rigidus is a degenerative arthritis of the first Metatarsophalangeal (MTP) joint that results in a limited range of motion due to osteophyte formation and joint space narrowing [1-3]. This disease was initially described by Davies-Colley in 1887 as hallux flexus [4]. Conservative treatment may include use of insoles and nonsteroidal anti-inflammatory drugs in the early stages. If nonoperative treatment fails, surgery may be considered. Various surgeries have been prescribed for hallux rigidus, including cheilectomy, proximal phalangeal osteotomy, metatarsal osteotomy, Capsular Interposition Arthroplasty (CIA), MTP fusion (arthrodesis), hemiarthroplasty, and total joint replacement (implant arthroplasty) [1]. Cheilectomy, proximal phalangeal osteotomy, and metatarsal osteotomy are applied in the early disease stage. However, CIA, arthrodesis, and implant arthroplasty are applied in the end stage, but no surgical procedures are established in this stage. CIA is a low-cost and motion-sparing procedure that uses autologous tissue [5-7], all of which are the reasons why CIA is the first-line surgery for end-stage hallux rigidus in our institution. The purpose of this study was to present our institution’s experience and the short-term clinical results of CIA for end-stage hallux rigidus.

Materials and Methods

This was a retrospective and descriptive study of 10 patients (10 feet) with end-stage osteoarthritis of the MTP joint (Hattrup Grade III, hallux rigidus per the Hattrup classification [2]) treated by CIA from November 2010 to November 2015 in our institution. The study cohort was comprised of 10 patients (10 feet), including 8 women and 2 men. Mean age at surgery was 67.1 years (range, 51-80 years) and mean duration of follow-up was 16.8 months (range, 12-23 months). Clinical and radiographic studies were performed at the initial examination and atevery outpatient visit until final follow-up. All charts were reviewed to collect the preoperative and postoperative (final follow-up) Range of Motion (ROM) measurements of the hallux MTP joint and the Japan Society for Surgery of the Foot (JSSF) scores [8]. The JSSF is a 100-point clinical score comprising three items: a pain score (40 points maximum), functionality (45 points maximum), and alignment (15 points maximum). Data was also available for the Self-Administered Foot Evaluation Questionnaire (SAFE-Q) scores [9,10], which use 5 subscales: 1: Pain and Pain-Related, 2: Physical Functioning and Daily Living, 3: Social Functioning, 4: Shoe-Related, and 5: General Health and Well Being. The subscales were scored between zero to 100. This questionnaire is at the time of the final postoperative visit. Statistical analysis was performed using SPSS software (IBM, Chicago, USA). Preoperative and final follow-up clinical data (ROM measurements, JSSF score and SAFE-Q scores) were compared using a paired t-test. A P Value of <0.05 was considered statistically significant.